Related Experiment Video
Updated: Aug 15, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity
Pao-Chi Liao1, Yu-Min Kuo, Hen-Chia Hsu
1Department of Environmental and Occupational Health, National Cheng Kung University College of Medicine, Tainan, Taiwan.
Abstract:
The present study aimed to examine the proteins involved in the methamphetamine (MA)-induced nigrostriatal dopaminergic toxicity. Infusion of anisomycin into striatum and substantia nigra both abolished the MA-induced striatal dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) depletions, indicating a critical role of local protein synthesis in determining such dopaminergic toxicity. Moreover, local protein synthesis blockade reversed this neurotoxicity via a temperature-independent mechanism. We then employed a proteomic approach, two-dimensional gel electrophoresis (2-DE) in conjunction with mass spectrometry analysis, to identify the protein candidates associated with the MA-induced neurotoxicity. In striatal samples, 2-DE analysis revealed that the intensities of nine protein spots were altered by MA treatment. Mass spectrometry analysis allowed us to identify five proteins, including an up-regulated protein, alpha-synuclein, and four down-regulated proteins, ATPase, F-actin capping protein beta subunit, ubiquitin carboxy-terminal hydrolase/PGP 9.5, and peroxidase. MA-altered expression levels of alpha-synuclein and ubiquitin carboxy-terminal hydrolase/PGP 9.5 in striata were confirmed by western blotting analysis. Taken together, these results suggest that local up-regulation of alpha-synuclein and down-regulation of ubiquitin carboxy-terminal hydrolase/PGP 9.5 could be linked to the MA-induced dopaminergic terminal toxicity.
Insights
Methamphetamine (MA) neurotoxicity involves local protein synthesis, with alpha-synuclein up-regulation and ubiquitin carboxy-terminal hydrolase/PGP 9.5 down-regulation linked to dopaminergic damage.
Area of Science:
- Neuroscience
- Proteomics
- Neuropharmacology
Background:
- Methamphetamine (MA) causes nigrostriatal dopaminergic toxicity.
- Local protein synthesis plays a role in this neurotoxicity.
Purpose of the Study:
- To identify proteins involved in MA-induced dopaminergic neurotoxicity.
- To elucidate the mechanism of MA neurotoxicity.
Main Methods:
- Proteomic analysis using two-dimensional gel electrophoresis (2-DE) and mass spectrometry.
- Inhibition of local protein synthesis with anisomycin.
- Western blotting to confirm protein expression changes.
Main Results:
- MA treatment altered the expression of nine protein spots in striatal samples.
- Alpha-synuclein was up-regulated, while ATPase, F-actin capping protein beta subunit, ubiquitin carboxy-terminal hydrolase/PGP 9.5, and peroxidase were down-regulated.
- Anisomycin abolished MA-induced dopamine and DOPAC depletions, indicating a role for local protein synthesis.
Conclusions:
- Local up-regulation of alpha-synuclein and down-regulation of ubiquitin carboxy-terminal hydrolase/PGP 9.5 are associated with MA-induced dopaminergic terminal toxicity.
- Local protein synthesis blockade reverses MA neurotoxicity through a temperature-independent mechanism.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Parkinson Disease ll: Pathophysiology

